Icosagen (Estonia)
Icosagen is an Estonian biotechnology companies providing custom research programs and services to the Biopharmaceutical industry, including antibody discovery, protein production, and GMP manufacturing. Formed in 1999 as Quattromed AS, it was renamed Icosagen in 2009. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Icosagen (Estonia), Estonia, covering academic research published from 2004 to 2024. Read More.
Open Access Percentage
75%
Total
Publications
75
Total Open
Publications
56
Total
Citations
1.4K
Open Access
Percentage
75%
Total
Publications
75
Total Open
Publications
56
Total
Citations
1.4K
Breakdown
Publisher Open
16%
Both
50%
Other Platform Open
9%
Closed
25%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 72%
35
Hybrid 18%
9
No Guarantees 10%
5
Other Platform Open
Domain 66%
29
Institution 36%
16
Other Internet 23%
10
Preprint 11%
5
Public 7%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 29 |
DOI | Other Internet | 10 |
Royal Netherlands Academy of Arts and Sciences | Institution | 7 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 3 |
Figshare | Public | 3 |
Europe PMC | Domain | 3 |
bioRxiv | Preprint | 3 |
University of Tartu | Institution | 2 |
Office of Scientific and Technical Information | Institution | 2 |
medRxiv | Preprint | 2 |